Efficacy and Safety of EsoDuo®

Clinical trial NCT06430047 · UNKNOWN

Trial details

NCT number: NCT06430047
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Gastro Esophageal Reflux

Start date: 2022-11-25
Primary completion: 2025-01-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.